1. Home
  2. EDSA vs LSH Comparison

EDSA vs LSH Comparison

Compare EDSA & LSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EDSA
  • LSH
  • Stock Information
  • Founded
  • EDSA 2015
  • LSH 2018
  • Country
  • EDSA Canada
  • LSH United States
  • Employees
  • EDSA N/A
  • LSH N/A
  • Industry
  • EDSA Biotechnology: Pharmaceutical Preparations
  • LSH
  • Sector
  • EDSA Health Care
  • LSH
  • Exchange
  • EDSA Nasdaq
  • LSH NYSE
  • Market Cap
  • EDSA 6.2M
  • LSH 7.3M
  • IPO Year
  • EDSA N/A
  • LSH 2024
  • Fundamental
  • Price
  • EDSA $2.36
  • LSH $1.03
  • Analyst Decision
  • EDSA Strong Buy
  • LSH
  • Analyst Count
  • EDSA 1
  • LSH 0
  • Target Price
  • EDSA $21.00
  • LSH N/A
  • AVG Volume (30 Days)
  • EDSA 8.9K
  • LSH 37.3K
  • Earning Date
  • EDSA 05-09-2025
  • LSH 05-01-2025
  • Dividend Yield
  • EDSA N/A
  • LSH N/A
  • EPS Growth
  • EDSA N/A
  • LSH N/A
  • EPS
  • EDSA N/A
  • LSH N/A
  • Revenue
  • EDSA N/A
  • LSH $16,927,719.00
  • Revenue This Year
  • EDSA N/A
  • LSH N/A
  • Revenue Next Year
  • EDSA N/A
  • LSH N/A
  • P/E Ratio
  • EDSA N/A
  • LSH N/A
  • Revenue Growth
  • EDSA N/A
  • LSH 2.84
  • 52 Week Low
  • EDSA $1.55
  • LSH $0.88
  • 52 Week High
  • EDSA $5.59
  • LSH $5.37
  • Technical
  • Relative Strength Index (RSI)
  • EDSA 51.83
  • LSH N/A
  • Support Level
  • EDSA $2.29
  • LSH N/A
  • Resistance Level
  • EDSA $2.40
  • LSH N/A
  • Average True Range (ATR)
  • EDSA 0.12
  • LSH 0.00
  • MACD
  • EDSA 0.00
  • LSH 0.00
  • Stochastic Oscillator
  • EDSA 87.88
  • LSH 0.00

About EDSA Edesa Biotech Inc.

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.

About LSH LAKESIDE HOLDING LTD

Lakeside Holding Ltd i an integrated cross-border supply chain solution provider with a strategic focus on the Asian market including China and South Korea. It provides customized cross-border ocean freight solutions and airfreight solutions in the U.S, including cross-border freight consolidation and forwarding services; customs clearance services; warehousing and distribution services and U.S. domestic ground transportation services.

Share on Social Networks: